These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4144065)

  • 1. [The effect of 1-(isopropylamino)-3-(m-toyloxy)-2-propanol hydrochloride (Doberol) on the bronchial system after oral administration].
    Günthner W
    Eur J Clin Pharmacol; 1972 Jun; 4(3):185-90. PubMed ID: 4144065
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological study of a new adrenergic beta receptor blocking agent: 1-isopropylamino-3-(1,2,3,4-tetrahydro-1,4-ethano-5-naphthoxy)-2-propanol hydrochloride (K4423)].
    Bergamaschi M; Mandelli V; Tommasini R; Turba C; Usardi MM
    Boll Chim Farm; 1972 Nov; 111(11):667-87. PubMed ID: 4144099
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of anti-inflammatory activity of -adrenoceptor blocking agents.
    Bhalla TN; Sinha JN; Tangri KK; Bhargava KP
    Eur J Pharmacol; 1972 Dec; 20(3):366-8. PubMed ID: 4404943
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of some -adrenergic blocking agents on the acetylcholine content of heart. An experimental study in mice.
    Khanna NK
    Eur J Pharmacol; 1972 Feb; 17(2):309-11. PubMed ID: 4402099
    [No Abstract]   [Full Text] [Related]  

  • 5. Properties of 1-isopropylamino-3-(4-indanoxy)-2-propanol (USVC 6524), an adrenergic -receptor blocking agent.
    Marmo E; Saini RK; Caputi AP
    Farmaco Prat; 1972 Dec; 27(12):661-87. PubMed ID: 4405106
    [No Abstract]   [Full Text] [Related]  

  • 6. Electrophysiological evaluation of anesthetic actions of some beta-adrenergic blockers on guinea-pig cardiac muscles.
    Washizu Y
    Arch Int Pharmacodyn Ther; 1973 Apr; 202(2):263-9. PubMed ID: 4144372
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influence of an alpha- and beta-receptor blockade on the dynamics of insulin secretion in dogs following increased dosage of various sulfonylureas].
    Cordes U; Beyer J; Sell G; Haupt E; Schöffling K
    Verh Dtsch Ges Inn Med; 1971; 77():1069-72. PubMed ID: 4405360
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of two new beta-blocking drugs on heart rate and blood pressure during passive tilting in man.
    Fuccella LM; Reban J; Bassini F; Lattes E; Mandelli V
    Eur J Clin Pharmacol; 1971 Dec; 4(1):12-7. PubMed ID: 4402874
    [No Abstract]   [Full Text] [Related]  

  • 9. Potentiation of bronchomotor responses by beta adrenergic antagonists.
    Diamond L
    J Pharmacol Exp Ther; 1972 Jun; 181(3):434-45. PubMed ID: 4402373
    [No Abstract]   [Full Text] [Related]  

  • 10. [Extrapancreatic effects of sulfonylurea compounds. V. Studies on the antilipolytic effect of glibornuride].
    Rosak C; Bartelt KM; Haupt E; Beyer J; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2181. PubMed ID: 4146791
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the nature of the bronchial -adrenoreceptors.
    Boissier JR; Advenier C; Giudicelli JF; Viars P
    Eur J Pharmacol; 1971 Jun; 15(1):101-9. PubMed ID: 4143978
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological studies on the combination of a coronary dilator with a beta-receptor blocking agent].
    Kadatz R; Diederen W
    Arzneimittelforschung; 1972 Sep; 22(9):1449-54. PubMed ID: 4405011
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta-adrenergic blocking activity and haemodynamic effects in man of Kö 1313, a new beta-adrenergic antagonist.
    Gilfrich HJ; Rahn KH; Nicolescu RF
    Eur J Clin Pharmacol; 1971 Sep; 3(4):204-8. PubMed ID: 4402827
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of propranolol upon the hemoglobin-oxygen dissociation curve.
    Pendleton RG; Newman DJ; Sherman SS; Brann EG; Maya WE
    J Pharmacol Exp Ther; 1972 Mar; 180(3):647-56. PubMed ID: 4401159
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of -adrenoceptor antagonists on the decline of the chronotropic response to isoprenaline.
    Fenyvesi T; George CF; Dollery CT
    J Pharm Pharmacol; 1972 Apr; 24(4):313-7. PubMed ID: 4402839
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of oxprenolol (Trasicor, Ciba 39089-Ba) on patterns of urinary sodium excretion in man.
    Singh BN; Till MR; Kelly DT
    Am J Cardiol; 1971 Apr; 27(4):372-5. PubMed ID: 4396725
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac toxicity of -lytic drugs.
    Roba J
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:120-. PubMed ID: 4403294
    [No Abstract]   [Full Text] [Related]  

  • 18. Raised serum-lipids unaffected by beta-blockade.
    Lloyd-Mostyn RH; Krikler DM
    Lancet; 1970 Nov; 2(7681):1040. PubMed ID: 4098084
    [No Abstract]   [Full Text] [Related]  

  • 19. Salivation in mice as an index of adrenergic activity. I. Salivation and temperature responses to d-amphetamine and other sialogogues and the effects of adrenergic blocking agents.
    Maling HM; Williams MA; Koppanyi T
    Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):318-32. PubMed ID: 4403618
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical-experimental studies on the bronchoconstrictor activity of Dalzic (ICI 50 172)].
    Günthner W
    Ther Ggw; 1973 Mar; 112(3):420 passim. PubMed ID: 4144787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.